Upsher-Smith To Pay £223M For UK Drug Co. Proximagen
Minnesota-based pharmaceuticals manufacturer Upsher-Smith Laboratories Inc. will shore up its product pipeline with the £223 million ($346.7 million) purchase of British biotech company Proximagen Group PLC, a neuroscience industry specialist, the...To view the full article, register now.
Already a subscriber? Click here to view full article